Literature DB >> 27915229

Increased orthogeriatrician involvement in hip fracture care and its impact on mortality in England.

Jenny Neuburger1,2,3, Colin Currie4, Robert Wakeman5, Antony Johansen6, Carmen Tsang1,2, Fay Plant7, Helen Wilson8, David A Cromwell1,2, Jan van der Meulen1, Bianca De Stavola9.   

Abstract

Objectives: to describe the increase in orthogeriatrician involvement in hip fracture care in England and its association with improvements in time to surgery and mortality. Study design: analysis of Hospital Episode Statistics for 196,401 patients presenting with hip fracture to 150 hospitals in England between 1 April 2010 and 28 February 2014, combined with data on orthogeriatrician hours from a national organisational survey.
Methods: we examined changes in the average number of hours worked by orthogeriatricians in orthopaedic departments per patient with hip fracture, and their potential effect on mortality within 30 days of presentation. The role of prompt surgery (on day of or day after presentation) was explored as a potential confounding factor. Associations were assessed using conditional Poisson regression models with adjustment for patients' sex, age and comorbidity and year, with hospitals treated as fixed effects.
Results: between 2010 and 2013, there was an increase of 2.5 hours per patient in the median number of hours worked by orthogeriatricians-from 1.5 to 4.0 hours. An increase of 2.5 hours per patient was associated with a relative reduction in mortality of 3.4% (95% confidence interval 0.9% to 5.9%, P = 0.01). This corresponds to an absolute reduction of approximately 0.3%. Higher numbers of orthogeriatrician hours were associated with higher rates of prompt surgery, but were independently associated with lower mortality.
Conclusion: in the context of initiatives to improve hip fracture care, we identified statistically significant and robust associations between increased orthogeriatrician hours per patient and reduced 30-day mortality. © Crown copyright 2016

Entities:  

Keywords:  hip fracture; mortality; older people; orthogeriatrics

Mesh:

Year:  2017        PMID: 27915229     DOI: 10.1093/ageing/afw201

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  5 in total

1.  The Dutch Hip Fracture Audit: evaluation of the quality of multidisciplinary hip fracture care in the Netherlands.

Authors:  Stijn C Voeten; Arend J Arends; Michel W J M Wouters; Bastiaan J Blom; Martin J Heetveld; Monique S Slee-Valentijn; Pieta Krijnen; Inger B Schipper; J H Han Hegeman
Journal:  Arch Osteoporos       Date:  2019-03-01       Impact factor: 2.617

2.  Increased Geriatric Treatment Frequency Improves Mobility and Secondary Fracture Prevention in Older Adult Hip Fracture Patients-An Observational Cohort Study of 23,828 Patients from the Registry for Geriatric Trauma (ATR-DGU).

Authors:  Johannes Gleich; Evi Fleischhacker; Katherine Rascher; Thomas Friess; Christian Kammerlander; Wolfgang Böcker; Benjamin Bücking; Ulrich Liener; Michael Drey; Christine Höfer; Carl Neuerburg
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

3.  Achieving the hip fracture Best Practise Tariff during the COVID-19 pandemic.

Authors:  Mohammed Ali; Ahmed Fadulelmola; Marie Urwin; Cristian Nita
Journal:  J Frailty Sarcopenia Falls       Date:  2022-03-01

4.  Multiple hospital organisational factors are associated with adverse patient outcomes post-hip fracture in England and Wales: the REDUCE record-linkage cohort study.

Authors:  Rita Patel; Andrew Judge; Antony Johansen; Elsa M R Marques; Jill Griffin; Marianne Bradshaw; Sarah Drew; Katie Whale; Tim Chesser; Xavier L Griffin; Muhammad K Javaid; Yoav Ben-Shlomo; Celia L Gregson
Journal:  Age Ageing       Date:  2022-08-02       Impact factor: 12.782

5.  Mortality, risk factors and causes of death in Swedish patients with open tibial fractures - a nationwide study of 3, 777 patients.

Authors:  Ulrika Tampe; Lukas W Widmer; Rüdiger J Weiss; Karl-Åke Jansson
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-07-25       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.